Acquisitions As The Silent Partner In Biotech Liquidity: IPO Vs. M&A Exit Paths Posted on November 22, 2014 by henrykotula • Posted in Uncategorized • Tagged Biotech, M&A, Private Equity, Venture Capital • Leave a comment http://www.forbes.com/sites/brucebooth/2014/10/27/acquisitions-as-the-silent-partner-in-biotech-liquidity-ipo-vs-ma-exit-paths/ Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Like Loading... Related
HENRY KOTULA 